Salmeterol enhances the cardiac response to gene therapy in Pompe disease.

about

AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe Disease.

P2860

Q44403697-5F23F3EB-A3E5-42D5-9A22-9707067ADB65

P2860

Salmeterol enhances the cardiac response to gene therapy in Pompe disease.

Item

http://www.wikidata.org/entity/Q36803863

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Salmeterol enhances the cardiac response to gene therapy in Pompe disease.

@ast

Salmeterol enhances the cardiac response to gene therapy in Pompe disease.

@en

type

Item

label

Salmeterol enhances the cardiac response to gene therapy in Pompe disease.

@ast

Salmeterol enhances the cardiac response to gene therapy in Pompe disease.

@en

prefLabel

Salmeterol enhances the cardiac response to gene therapy in Pompe disease.

@ast

Salmeterol enhances the cardiac response to gene therapy in Pompe disease.

@en

P1476

Salmeterol enhances the cardiac response to gene therapy in Pompe disease.

@en

P2093

Dwight D Koeberl

http://www.w3.org/2001/XMLSchema#string

Songtao Li

http://www.w3.org/2001/XMLSchema#string

P2860

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

Role of autophagy in the pathogenesis of Pompe disease.

Enhanced efficacy from gene therapy in Pompe disease using coreceptor blockade

Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle

Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.

Hypoxia and dehydroepiandrosterone in old age: a mouse survival study.

When more is less: excess and deficiency of autophagy coexist in skeletal muscle in Pompe disease.

β2 Agonists enhance the efficacy of simultaneous enzyme replacement therapy in murine Pompe disease.

Adjunctive β2-agonists reverse neuromuscular involvement in murine Pompe disease.

Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance.

P304

35-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YMGME.2016.03.006

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Sung Ok Han

P577

2016-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27017193

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

P932

4833676

http://www.w3.org/2001/XMLSchema#string

Salmeterol enhances the cardiac response to gene therapy in Pompe disease.

about

P2860

P2860

Salmeterol enhances the cardiac response to gene therapy in Pompe disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932